Description
Clinical Description
Facetem S (1 × 1.5ml) is a collagen-stimulating injectable aesthetic device designed for professional use in regenerative aesthetic procedures. Unlike traditional hyaluronic acid dermal fillers that primarily provide immediate volume through gel implantation, Facetem S belongs to the category of biostimulatory injectables intended to support gradual improvement in skin quality and tissue characteristics.
Facetem S contains calcium hydroxyapatite (CaHA) microspheres suspended in a carrier gel, a technology widely used in collagen stimulation treatments. Following injection, the CaHA particles act as a scaffold that can support collagen formation around the treated area while the carrier gel provides the initial product matrix.
The product is intended for qualified medical practitioners performing aesthetic procedures where improvement of skin firmness, elasticity, and tissue structure is required. The exact approved indications, injection parameters, and clinical protocols should always be confirmed through the official manufacturer documentation.
What Facetem S Is Similar To
Facetem S belongs to the collagen-stimulating injectable category and can be compared with other calcium hydroxyapatite-based products such as Radiesse.
Both Facetem S and Radiesse use calcium hydroxyapatite (CaHA) microspheres as the active biostimulatory component. CaHA-based injectables differ from standard hyaluronic acid fillers because their mechanism involves supporting collagen production and improving tissue characteristics over time rather than relying solely on direct gel volume replacement.
Facetem S may also be compared conceptually with other collagen stimulators such as PLLA-based products, although the polymer composition, indications, regulatory status, and clinical protocols differ between technologies.
The choice between different injectable categories depends on product indications, practitioner assessment, patient suitability, and treatment objectives.
This comparison is provided for clinical orientation only and does not imply interchangeability.
Treatment Areas / Indications
According to available product information, Facetem S is used as a collagen-stimulating injectable for professional aesthetic applications.
Reported treatment applications include:
- Facial skin rejuvenation
- Improvement of skin firmness and elasticity
- Tissue quality enhancement procedures
- Areas requiring collagen stimulation
Specific approved anatomical treatment areas and indications should be confirmed from the official Facetem S IFU.
Usage / Administration (IFU-Only Section)
Facetem S should be administered only by qualified medical professionals trained in injectable aesthetic procedures.
The manufacturer’s official IFU should be followed for all administration parameters.
Available information:
Some practitioners use specific dilution approaches, cannula techniques, or injection patterns with calcium hydroxyapatite products; however, these approaches are not considered official Facetem S manufacturer guidance unless specifically included within the IFU.
Ingredient List
Facetem S contains a calcium hydroxyapatite-based formulation designed for collagen stimulation.
Available formulation information:
- Calcium hydroxyapatite (CaHA) microspheres – active biostimulatory component
- Carrier gel – suspension medium for CaHA particles
Presentation & Longevity
Presentation
Facetem S is supplied as:
- 1 × 1.5ml syringe
The exact packaging configuration should be verified against the current manufacturer packaging and product documentation.
Longevity
Calcium hydroxyapatite-based collagen stimulators are generally designed to provide gradual tissue effects that develop over time as the body responds to the implanted material.
The duration of visible results can vary depending on:
- individual patient characteristics,
- treated area,
- injection technique,
- biological response.
A specific manufacturer-confirmed longevity period for Facetem S was not identified in the publicly available product information.
Safety Notes / Contraindications
Facetem S is an injectable medical aesthetic device intended for use by qualified healthcare professionals with appropriate training in aesthetic injection procedures.
Before treatment, practitioners should evaluate patient suitability and review relevant medical history, potential allergies, and contraindications according to the manufacturer’s Instructions for Use (IFU).
Important safety considerations include:
- Use is contraindicated in patients with known hypersensitivity to any component of the product.
- Treatment should not be performed in areas with active skin infections, inflammation, or compromised skin integrity.
- Patients with conditions that may affect healing or increase procedural risks should be assessed carefully before treatment.
- The product should not be used outside the indications and administration guidelines provided by the manufacturer.
As with other injectable aesthetic products, temporary procedure-related effects such as redness, swelling, bruising, tenderness, or discomfort may occur following treatment.
Patients should be informed that individual outcomes vary depending on factors including skin condition, treatment area, practitioner technique, and biological response.
Regulatory Status
Facetem S is marketed as a professional collagen-stimulating injectable based on calcium hydroxyapatite (CaHA) technology.
Available product information identifies Facetem S as:
- Product category: Calcium hydroxyapatite collagen stimulator
- Presentation: 1 × 1.5ml syringe
- Intended users: Qualified medical aesthetic professionals
Regulatory classification and certification details should be verified through the official product packaging, manufacturer documentation, and applicable regulatory databases.
FAQ
1. What is Facetem S (1 × 1.5ml) and how does it work?
Facetem S is a collagen-stimulating injectable containing calcium hydroxyapatite (CaHA) microspheres suspended in a carrier gel. CaHA-based products are designed to provide an initial structural effect while supporting a gradual biological response associated with collagen formation around the injected material. Unlike traditional HA fillers that primarily provide volume through a gel matrix, CaHA products are categorised as biostimulatory injectables. [1]
The exact clinical effects and treatment outcomes depend on the product instructions, practitioner assessment, and individual patient response.
2. Is Facetem S a dermal filler or a collagen stimulator?
Facetem S is generally classified as a calcium hydroxyapatite-based collagen stimulator. While CaHA products may provide some immediate filling effect from the carrier gel, their main distinction from conventional hyaluronic acid fillers is their association with longer-term tissue remodelling processes.
Traditional HA fillers mainly rely on cross-linked hyaluronic acid gel for volume correction, whereas collagen stimulators are designed to encourage biological changes within the treated tissue. The two categories have different compositions, mechanisms, and clinical considerations.
3. How long do results from Facetem S last?
The duration of results following calcium hydroxyapatite-based injectable treatments varies depending on several factors, including the treatment area, injection technique, patient characteristics, and individual collagen response.
Published literature regarding CaHA-based injectable materials reports that clinical effects may persist beyond the immediate treatment period due to ongoing tissue response. However, the exact longevity of Facetem S should be confirmed from manufacturer-supported clinical documentation.
Manufacturer-confirmed longevity for Facetem S: not provided in publicly available documentation.
4. How does Facetem S compare with other collagen stimulators?
Facetem S can be compared with other collagen-stimulating injectable technologies, including calcium hydroxyapatite products and PLLA-based biostimulators.
The main difference between these technologies is the active material used. Facetem S uses CaHA microspheres, while PLLA products use biodegradable poly-L-lactic acid particles. Both categories aim to stimulate collagen-related tissue responses, but they differ in formulation, regulatory indications, and clinical protocols.
Products should not be considered interchangeable, and practitioners should follow each manufacturer’s specific instructions.
5. Who can administer Facetem S?
Facetem S should only be administered by qualified medical professionals who have appropriate training and experience with injectable aesthetic devices.
The administering practitioner is responsible for:
- assessing patient suitability,
- reviewing contraindications,
- following the manufacturer’s IFU,
- maintaining appropriate aseptic conditions during treatment.
Patients considering injectable aesthetic procedures should seek consultation with a suitably qualified healthcare professional.
